IRC
HARP

Investors Research Corp’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Investors Research Corp’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6
Closed -$45 – 1129
2023
Q1 		$45 Hold
6
– – ﹤0.01% 1111
2022
Q4 		$44 Hold
6
– – ﹤0.01% 1128
2022
Q3 		$0 Hold
6
– – ﹤0.01% 1157
2022
Q2 		$0 Hold
6
– – ﹤0.01% 1174
2022
Q1 		$0 Hold
6
– – ﹤0.01% 1111
2021
Q4 		$0 Hold
6
– – ﹤0.01% 1061
2021
Q3 		$0 Hold
6
– – ﹤0.01% 1046
2021
Q2 		$1K Sell
6
-1
-14% -$191 ﹤0.01% 962
2021
Q1 		$1K Hold
7
– – ﹤0.01% 953
2020
Q4 		$1K Hold
7
– – ﹤0.01% 1060
2020
Q3 		$1K Buy
+7
New +$1.01K ﹤0.01% 1070

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Investors Research Corp's HARP Position: Q2 2023 in Review

Investors Research Corp sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 6 shares — an estimated $45 sold.

Investors Research Corp first reported a position in HARP in Q3 2020 and held it in 11 quarters. The position peaked at $1K in Q2 2021. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

  • Investors Research Corp reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Investors Research Corp sold 6 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $45.
  • Investors Research Corp first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Investors Research Corp's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Investors Research Corp's 13F filing for Q2 2023, filed 14 Aug 2023.